Literature DB >> 11738931

The voltage-gated sodium channel gene SCN2A and idiopathic generalized epilepsy.

K Haug1, K Hallmann, J Rebstock, J Dullinger, S Muth, F Haverkamp, H Pfeiffer, B Rau, C E Elger, P Propping, A Heils.   

Abstract

We tested the hypothesis that genetic variation in the human sodium channel gene SCN2A confers liability to idiopathic generalized epilepsy (IGE). We performed a systematic search for mutations in 46 familial IGE cases and detected three novel polymorphisms, however, allele frequencies did not differ significantly between patients and controls. A rare mutation (R1918H) was identified in one patient but was absent in one further affected family member. Thus, our results do not suggest a major role of SCN2A in the etiology of IGE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738931     DOI: 10.1016/s0920-1211(01)00312-6

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

Review 1.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population.

Authors:  Ram Lakhan; Ritu Kumari; Usha K Misra; Jayanti Kalita; Sunil Pradhan; Balraj Mittal
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

3.  SCN8A encephalopathy: Research progress and prospects.

Authors:  Miriam H Meisler; Guy Helman; Michael F Hammer; Brandy E Fureman; William D Gaillard; Alan L Goldin; Shinichi Hirose; Atsushi Ishii; Barbara L Kroner; Christoph Lossin; Heather C Mefford; Jack M Parent; Manoj Patel; John Schreiber; Randall Stewart; Vicky Whittemore; Karen Wilcox; Jacy L Wagnon; Phillip L Pearl; Adeline Vanderver; Ingrid E Scheffer
Journal:  Epilepsia       Date:  2016-06-08       Impact factor: 5.864

Review 4.  Current view on regulation of voltage-gated sodium channels by calcium and auxiliary proteins.

Authors:  Geoffrey S Pitt; Seok-Yong Lee
Journal:  Protein Sci       Date:  2016-06-13       Impact factor: 6.725

5.  Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population.

Authors:  Ritu Kumari; Ram Lakhan; R K Garg; J Kalita; U K Misra; Balraj Mittal
Journal:  Indian J Hum Genet       Date:  2011-05

6.  Structural analyses of Ca²⁺/CaM interaction with NaV channel C-termini reveal mechanisms of calcium-dependent regulation.

Authors:  Chaojian Wang; Ben C Chung; Haidun Yan; Hong-Gang Wang; Seok-Yong Lee; Geoffrey S Pitt
Journal:  Nat Commun       Date:  2014-09-18       Impact factor: 14.919

7.  Calmodulin limits pathogenic Na+ channel persistent current.

Authors:  Haidun Yan; Chaojian Wang; Steven O Marx; Geoffrey S Pitt
Journal:  J Gen Physiol       Date:  2017-01-13       Impact factor: 4.086

Review 8.  Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection.

Authors:  Alfredo B Cuéllar-Barboza; Susan L McElroy; Marin Veldic; Balwinder Singh; Simon Kung; Francisco Romo-Nava; Nicolas A Nunez; Alejandra Cabello-Arreola; Brandon J Coombes; Miguel Prieto; Hannah K Betcher; Katherine M Moore; Stacey J Winham; Joanna M Biernacka; Mark A Frye
Journal:  Int J Bipolar Disord       Date:  2020-07-04

9.  Clinical application of exome sequencing in undiagnosed genetic conditions.

Authors:  Anna C Need; Vandana Shashi; Yuki Hitomi; Kelly Schoch; Kevin V Shianna; Marie T McDonald; Miriam H Meisler; David B Goldstein
Journal:  J Med Genet       Date:  2012-05-11       Impact factor: 6.318

Review 10.  Calmodulin and Ca(2+) control of voltage gated Na(+) channels.

Authors:  Sandra B Gabelli; Jesse B Yoder; Gordon F Tomaselli; L Mario Amzel
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.